There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
Key Elements in the Management and Treatment of Schizophrenia
Credit(s):
1 Contact Hour(s) of CE; 0.75 of which may be applied towards Pharmacology
Released: 11/13/2024 Expires: 11/30/2025 (subject to change)
CE for this activity will not be available after this date.
This activity includes closed captioning.
Delivery Note: The content for this activity was previously presented during the 2024 AANP Fall Conference. If you already completed the content of this activity while attending the live conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies.
Overview
Schizophrenia affects an estimated 3.2 million people in the United States and most NPs see patients with this disorder in their practices. Learn about emerging pharmacological treatments for schizophrenia and strategies to optimize adherence to plan of care.
Schizophrenia Program Update Shortly after this presentation was recorded, the FDA approved a new treatment for schizophrenia, an oral combination of xanomeline and trospium chloride, with the brand name Cobenfy. Please refer to the FDA News Release to learn more about it. FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia | FDA. Objectives
Discuss the burden of disease faced by people living with schizophrenia.
Identify the clinical presentation of the cognitive impairment associated with schizophrenia.
Examine the currently available and emerging pharmacological treatments for schizophrenia.
Apply treatment strategies that optimize maximal adherence to the schizophrenia plan of care.
Speakers Lisa Anderson DNP, APRN, PMHNP-BC Shonda Phelon DNP, APMHNP-BC, FNP-BC, GNP-BC Disclosure This program was planned in accordance with AANP CE Standards and Policies.
The speakers have the following disclosures:
Lisa Anderson has nothing to disclose.
Shonda Phelon has nothing to disclosure.
All Planners involved in this activity have no relevant financial relationships to disclose. This presentation was first presented as a live event at AANP's 2024 Fall Conference in Reno, NV.
Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content:
Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
After completing all content, click on the blue Next Steps button:
Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information For questions or more information concerning this online CE activity,please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1 Contact Hour(s) of CE, 0.75 of which may be applied towards Pharmacology
Additional CE activities of interest
(OnDemand) Interrupting the Cycle of Cardiovascular-Renal-Metabolic (CVRM) Disease: Strategies for Adapting Practice to Evolving Guidelines
(OnDemand) Compassionate Care in Pain Management and Substance Use Disorder
(OnDemand) Advanced Pharmacology And Treatments In HTN
(OnDemand) Optimizing Pharmacotherapy for Dyslipidemia in Women: Tailored Approaches and Clinical Considerations
(OnDemand) Medication Assisted Treatment (MAT) For Substance Use Disorders
(OnDemand) Medications Used In Pulmonary Hypertension
(Accredited Podcast) Four Pillars of Medications for Heart Failure with Reduced Ejection Fraction (HFrEF)
(OnDemand) Embracing Neurodiversity: Navigating the New Landscape of Autism and ADHD Treatment
Adding Registration, Please wait...
